Scynexis Inc (SCYX)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $31.95M
Last updated: Nov 17, 2026 at 11:05 AM ET
Scynexis Inc (SCYX) Stock Forecast
Analysts expect Scynexis (SCYX) to earn -$3.13 per share in the fiscal year ending Dec 31, 2026, on revenue of $393330. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 33.3% |
| Buy | 2 | 66.7% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 2363.6%.
- Fiscal year ending Dec 31, 2026
- -$3.13
- EPS consensus, revenue $393330
- Fiscal year ending Dec 31, 2027
- -$1.95
- EPS consensus, revenue $9.69M
- Next report
- Mar 2, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$3.13 | -$3.48 to -$2.85 | 3 | $393330 | $235000 to $710000 | 3 |
| Dec 31, 2027 | -$1.95 | -$2.90 to -$0.37 | 3 | $9.69M | $1.95M to $17.42M | 2 |
Quarterly Estimates
The EPS consensus falls from -$0.54 for the quarter ending Dec 31, 2026 to -$0.58 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.54 | -$0.70 to -$0.25 | 5 | $927863 | N/A | 5 |
| Mar 31, 2027 | -$0.58 | -$0.69 to -$0.38 | 3 | $694500 | $449000 to $940000 | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$4.08.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$3.13 | -$2.91 | -$2.91 | -$2.91 | -$4.08 | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.95 | -$2.32 | -$2.32 | -$2.32 | -$2.52 | N/A |
Frequently Asked Questions About SCYX
What is the SCYX stock forecast?
Consensus analyst estimates put Scynexis's EPS at -$3.13 for the fiscal year ending Dec 31, 2026, on revenue of $393330. The consensus rating from 3 analysts is Buy.
How do analysts rate SCYX stock?
Of 3 analysts covering Scynexis, 1 rates it Strong Buy, 2 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from SCYX next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.13, with estimates from -$3.48 to -$2.85 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.95, with estimates from -$2.90 to -$0.37 from 3 analysts.
What revenue do analysts expect from Scynexis next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $393330, with estimates from $235000 to $710000. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $9.69M, with estimates from $1.95M to $17.42M.
How many analysts cover SCYX?
3 analysts rate Scynexis stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
SCYX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors